Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2.
Adolescent
Biomarkers
/ blood
Brain
/ diagnostic imaging
COVID-19
/ complications
Child
Child Behavior Disorders
/ epidemiology
Child, Preschool
Female
Follow-Up Studies
Humans
Infant
Inflammation
/ complications
Magnetic Resonance Imaging
Male
Nervous System Diseases
/ etiology
Retrospective Studies
Systemic Inflammatory Response Syndrome
/ complications
Thrombosis
/ blood
Journal
Neurology(R) neuroimmunology & neuroinflammation
ISSN: 2332-7812
Titre abrégé: Neurol Neuroimmunol Neuroinflamm
Pays: United States
ID NLM: 101636388
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
25
11
2020
accepted:
22
02
2021
entrez:
14
4
2021
pubmed:
15
4
2021
medline:
23
4
2021
Statut:
epublish
Résumé
Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) is a severe immune-mediated disorder. We aim to report the neurologic features of children with PIMS-TS. We identified children presenting to a large children's hospital with PIMS-TS from March to June 2020 and performed a retrospective medical note review, identifying clinical and investigative features alongside short-term outcome of children presenting with neurologic symptoms. Seventy-five patients with PIMS-TS were identified, 9 (12%) had neurologic involvement: altered conciseness (3), behavioral changes (3), focal neurology deficits (2), persistent headaches (2), hallucinations (2), excessive sleepiness (1), and new-onset focal seizures (1). Four patients had cranial images abnormalities. At 3-month follow-up, 1 child had died, 1 had hemiparesis, 3 had behavioral changes, and 4 completely recovered. Systemic inflammatory and prothrombotic markers were higher in patients with neurologic involvement (mean highest CRP 267 vs 202 mg/L, Broad neurologic features were found in 12% patients with PIMS-TS. By 3-month follow-up, half of these surviving children had recovered fully without neurologic impairment. Significantly higher systemic inflammatory markers were identified in children with neurologic involvement and in those who had not recovered fully.
Identifiants
pubmed: 33850037
pii: 8/4/e999
doi: 10.1212/NXI.0000000000000999
pmc: PMC8054962
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Références
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
Lancet Psychiatry. 2017 Oct;4(10):768-774
pubmed: 28882707
Pediatr Crit Care Med. 2015 Jun;16(5):e141-9
pubmed: 25901544
Ann Neurol. 2011 Aug;70(2):245-54
pubmed: 21823153
Nat Rev Rheumatol. 2020 Oct;16(10):581-589
pubmed: 32733003
Nat Med. 2020 Nov;26(11):1701-1707
pubmed: 32812012
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
Intensive Care Med. 2021 Jan;47(1):90-93
pubmed: 33057783
N Engl J Med. 2020 Sep 10;383(11):1085-1087
pubmed: 32706954
Lancet Child Adolesc Health. 2021 Mar;5(3):167-177
pubmed: 33338439
JAMA Neurol. 2020 Jul 1;:
pubmed: 32609336
Lancet Infect Dis. 2010 Dec;10(12):835-44
pubmed: 20952256
Handb Clin Neurol. 2016;133:39-59
pubmed: 27112670